Completed PHASE4 INTERVENTIONAL 3-arm NCT03315000

Effect of Vilanterol on Methacholine Challenge Results

The Effect of Vilanterol Against Methacholine-induced Bronchoconstriction in Mild Asthmatics

Sponsor: University of Saskatchewan

Conditions Asthma

Interventions Fluticasone Furoate Placebos Vilanterol and Fluticasone Furoate

Updated 5 times since 2017 Last updated: Oct 9, 2018 Started: Oct 13, 2017 Primary completion: May 1, 2018 Completion: May 1, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Asthma and is currently completed. University of Saskatchewan leads this study, which shows 5 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Nov 2018 — Jan 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Nov 2017 — Nov 2018 [monthly]

Recruiting PHASE4

First recorded

Oct 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Saskatchewan

Data source: University of Saskatchewan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Saskatoon, Canada